Through the deal, St. Louis-based Express Script members will be able to use inhaler sensors and connected mobile applications to manage their asthma or chronic obstructive pulmonary disease. The companies touted it as the largest respiratory digital health deployment with a pharmacy manager to date.
“Our vision is to help patients with asthma or COPD understand and proactively manage their condition, allowing them to breathe easier day in and day out. Propeller Health’s success in sensor technology empowers patients and enables our pulmonary pharmacists to provide the best care for patients,” Express Scripts CIO Dr. Glen Stettin said in a prepared statement.
The digital sensors, provided by Madison, Wisc.-based Propeller Health, allow for remote monitoring for patients in Express Scripts’ Pulmonary Care Value Program. The sensors use bluetooth to sync inhaler use to a mobile app, where activity trends can be reviewed by pulmonary pharmacists.
Patients can also track their symptoms and triggers through the app, as well as monitoring asthma condition forecasts and receiving other advice.
“We’re excited to partner with Express Scripts to bring the benefits of digital medicine and connected respiratory care to their members. With data and guidance from Propeller, members can expect to improve self-management and to receive timely, supportive assistance from the clinical respiratory team at Express Scripts,” Propeller co-founder & CEO David Van Sickle said in a press release.
Express Scripts said that in an early stage trial of the device, participating patients saw an 80% reduction in average rescue events daily and improvements to adherence to asthma controller medication.
In early October, Propeller Health released an application programming interface to give local asthma conditions to anyone within the U.S. who is interested in using that data.